Pharmacokinetic study of a novel sonosensitizer chlorin-e6 and its sonodynamic anti-cancer activity in hepatoma-22 tumor-bearing mice

Biopharmaceutics and Drug Disposition

Volumn 32, Issue 6, 2011, Pages 319-332

  Shi, Haitao ^a   Liu, Quanhong ^a   Qin, Xiaofei ^a   Wang, Pan ^a   Wang, Xiaobing ^a  

^a SHAANXI NORMAL UNIVERSITY   (China)

Author keywords

anti tumor effect; chlorin e6; hepatoma 22 solid tumor; in vivo optical imaging; pharmacokinetic studies; sonodynamic therapy

Indexed keywords

CHLORIN E6; RADIOSENSITIZING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; FEMALE; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; SPECTROFLUOROMETRY; TISSUE DISTRIBUTION; TUMOR GROWTH; TUMOR VOLUME; ULTRASOUND;

ANIMALS; ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DRUG EVALUATION, PRECLINICAL; FEMALE; FLUORESCENCE; HUMANS; LIVER NEOPLASMS; MICE; MICE, INBRED ICR; PORPHYRINS; RADIATION-SENSITIZING AGENTS; SPECTROMETRY, FLUORESCENCE; TREATMENT OUTCOME; ULTRASONIC THERAPY; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 80051892927     PISSN: 01422782     EISSN: 1099081X     Source Type: Journal    
DOI: 10.1002/bdd.761     Document Type: Article

References (48)

1. Umemura S, Yumita N, Nishifaki R, Umemura K,. Sonochemical activation of hematoporphyrin: a potential modality for cancer treatment. Proc IEEE Ultrason Symp 1989; 9: 955 - 960.
2. Yu T, Wang Z, Mason TJ,. A review of research into the uses of low level ultrasound in cancer therapy. Ultrason Sonochem 2004; 11: 95 - 103. (Pubitemid 38340858)
3. Rosenthal I, Sostaric JZ, Riesz P,. Sonodynamic therapy-a review of the synergistic effects of drugs and ultrasound. Ultrason Sonochem 2004; 11: 349 - 363. (Pubitemid 39070478)
4. Watanabe Y, Aoi A, Horie S, et al., Low-intensity ultrasound and microbubbles enhance the antitumor effect of cisplatin. Cancer Sci 2008; 99: 2525 - 2531.
5. Kuroki M, Hachimine K, Abe H, et al., Sonodynamic therapy of cancer using novel sonosensitizers. Anticancer Res 2007; 27: 3673 - 3677. (Pubitemid 47598429)
6. Sakusabe N, Okada K, Sato K, Kamada S, Yoshida Y, Suzuki T,. Enhanced sonodynamic antitumor effect of ultrasound in the presence of nonsteroidal anti-inflammatory drugs. Jpn J Cancer Res 1999; 90: 1146 - 1151.
7. Tachibana K, Feril LB Jr, Ikeda-Dantsuji Y,. Sonodynamic therapy. Ultrasonics 2008; 48: 253-259.
8. Hiraoka W, Honda H, Feril LB Jr, Kudo N, Kondo T,. Comparison between sonodynamic effect and photodynamic effect with photosensitizers on free radical formation and cell killing. Ultrason Sonochem 2006; 13: 535 - 542. (Pubitemid 44051962)
9. Umemura K, Yumita N, Nishigaki R, Umemura S,. Sonodynamically induced antitumor effect of pheophorbide A. Cancer Lett 1996; 102: 151-157. (Pubitemid 26097815)
10. Yumita N, Sasaki K, Umemura S, Nishigaki R,. Sonodynamically induced antitumor effect of a gallium-porphyrin complex, ATX-70. Jpn J Cancer Res 1996; 87: 310 - 316. (Pubitemid 26117063)
11. Yumita N, Nishigaki R, Umemura S,. Sonodynamically induced antitumor effect of Photofrin II on colon 26 carcinoma. J Cancer Res Clin Oncol 2000; 126: 601-606.
12. Yumita N, Sasaki K, Umemura S, Yukawa A, Nishigaki R,. Sonodynamically induced antitumor effect of gallium-porphyrin complex by focused ultrasound on experimental kidney tumor. Cancer Lett 1997; 112: 79-86. (Pubitemid 27067429)
13. Yumita N, Nishigaki R, Sakata I, Nakajima S, Umemura S,. Sonodynamically induced antitumor effect of 4-formyloximethylidene-3-hydroxy-2-vinyl-deuterio- porphynyl(IX)-6,7-diaspartic acid (ATX-S10). Jpn J Cancer Res 2000; 91: 255 - 260. (Pubitemid 30130757)
14. Nonaka M, Yamamoto M, Yoshino S, Umemura S, Sasaki K, Fukushima T,. Sonodynamic therapy consisting of focused ultrasound and a photosensitizer causes a selective antitumor effect in a rat intracranial glioma model. Anticancer Res 2009; 29: 943 - 950.
15. Hachimine K, Shibaguchi H, Kuroki M, et al., Sonodynamic therapy of cancer using a novel porphyrin derivative, DCPH-P-Na(I), which is devoid of photosensitivity. Cancer Sci 2007; 98: 916 - 920. (Pubitemid 46691831)
16. Saad AH, Hahn GM,. Ultrasound-enhanced effects of adriamycin against murine tumors. Ultrasound Med Biol 1992; 18: 715-723.
17. Umemura S, Kawabata K, Sasaki K, Yumita N, Umemura K, Nishigaki R,. Recent advances in sonodynamic approach to cancer therapy. Ultrason Sonochem 1996; 3: S187-S191. doi: 10.1016/S1350-4177(96)00024-7.
18. Kessel D, Jeffers R, Fowlkes JB, Cain C,. Porphyrin-induced enhancement of ultrasound cytotoxicity. Int J Radiat Biol 1994; 66: 221-228. (Pubitemid 24285387)
19. Tachibana K, Kimura N, Okumura M, Eguchi H, Tachibana S,. Enhancement of cell killing of HL-60 cells by ultrasound in the presence of the photosensitizing drug Photofrin II. Cancer Lett 1993; 72: 195 - 199. (Pubitemid 23275154)
20. Umemura S, Yumita N, Nishigaki R,. Enhancement of ultrasonically induced cell damage by a gallium-porphyrin complex, ATX-70. Jpn J Cancer Res 1993; 84: 582-588. (Pubitemid 23193819)
21. Tachibana K, Uchida T, Ogawa K, Yamashita N, Tamura K,. Induction of cell-membrane porosity by ultrasound. Lancet 1999; 353 (9162): 1409. (Pubitemid 29192415)
22. Yumita N, Kawabata K, Sasaki K, Umemura S,. Sonodynamic effect of erythrosin B on sarcoma 180 cells in vitro. Ultrason Sonochem 2002; 9: 259 - 265. (Pubitemid 34987692)
23. Okada K, Itoi E, Miyakoshi N, Nakajima M, Suzuki T, Nishida J,. Enhanced antitumor effect of ultrasound in the presence of piroxicam in a mouse air pouch model. Jpn J Cancer Res 2002; 93: 216-222. (Pubitemid 34223766)
24. Ma X, Pan H, Yi J,. Combination sonodynamic therapy with immunoadjuvant may be a promising new modality for cancer treatment. Med Hypotheses 2009; 72: 418 - 420.
25. Xiaohuai W, Lewis TJ, Mitchell D,. The tumoricidal effect of sonodynamic therapy (SDT) on S-180 sarcoma in mice. Integr Cancer Ther 2008; 7: 96 - 102. (Pubitemid 351806540)
26. Nelson JS, Roberts WG, Berns MW,. In vivo studies on the utilization of mono-L-aspartyl chlorin (NPe6) for photodynamic therapy. Cancer Res 1987; 47: 4681-4685. (Pubitemid 17127421)
27. Pandey RK, Bellnier DA, Smith KM, Dougherty TJ,. Chlorin and porphyrin derivatives as potential photosensitizers in photodynamic therapy. Photochem Photobiol 1991; 53: 65 - 72.
28. Sheyhedin I, Okunaka T, Kato H, et al., Localization of experimental submucosal esophageal tumor in rabbits by using mono-L-aspartyl chlorin e6 and long-wavelength photodynamic excitation. Lasers Surg Med 2000; 26: 83 - 89. (Pubitemid 30054276)
29. Nakamura H, Suzuki Y, Takeichi M, Saito T, Takayama M, Aizawa K,. Morphologic evaluation of the antitumor activity of photodynamic therapy (PDT) using mono-L-aspartyl chlorin e6 (NPe6) against uterine cervical carcinoma cell lines. Int J Gynecol Cancer 2002; 12: 177-186. (Pubitemid 34477879)
30. Chin WW, Heng PW, Bhuvaneswari R, Lau WK, Olivo M,. The potential application of chlorin e6-polyvinylpyrrolidone formulation in photodynamic therapy. Photochem Photobiol Sci 2006; 5: 1031-1037. (Pubitemid 44673146)
31. Chin WW, Heng PW, Olivo M,. Chlorin e6-polyvinylpyrrolidone mediated photosensitization is effective against human non-small cell lung carcinoma compared to small cell lung carcinoma xenografts. BMC Pharmacol 2007; 7: 15.
32. Usuda J, Kato H, Okunaka T, et al., Photodynamic therapy (PDT) for lung cancers. J Thorac Oncol 2006; 1: 489-493. (Pubitemid 47181428)
33. Yumita N, Han QS, Kitazumi I, Umemura S,. Sonodynamically-induced apoptosis, necrosis, and active oxygen generation by mono-l-aspartyl chlorin e6. Cancer Sci 2008; 99: 166 - 172. (Pubitemid 350239046)
34. Massoud TF, Gambhir SS,. Molecular imaging in living subjects: seeing fundamental biological processes in a new light. Genes Dev 2003; 17: 545 - 580. (Pubitemid 36307540)
35. Ntziachristos V, Bremer C, Weissleder R,. Fluorescence imaging with near-infrared light: new technological advances that enable in vivo molecular imaging. Eur Radiol 2003; 13: 195 - 208. (Pubitemid 36790510)
36. Sevick-Muraca EM, Houston JP, Gurfinkel M,. Fluorescence-enhanced, near infrared diagnostic imaging with contrast agents. Curr Opin Chem Biol 2002; 6: 642-650. (Pubitemid 35284196)
37. Ballou B, Fisher GW, Hakala TR, Farkas DL,. Tumor detection and visualization using cyanine fluorochrome-labeled antibodies. Biotechnol Prog 1997; 13: 649 - 658. (Pubitemid 27442053)
38. Ke S, Wen X, Gurfinkel M, et al., Near-infrared optical imaging of epidermal growth factor receptor in breast cancer xenografts. Cancer Res 2003; 63: 7870-7875. (Pubitemid 37466721)
39. Hawrysz DJ, Sevick-Muraca EM,. Developments toward diagnostic breast cancer imaging using near-infrared optical measurements and fluorescent contrast agents. Neoplasia 2000; 2: 388-417. (Pubitemid 32044786)
40. Achilefu S,. Lighting up tumors with receptor-specific optical molecular probes. Technol Cancer Res Treat 2004; 3: 393-409. (Pubitemid 39096612)
41. Mahmood U, Weissleder R,. Near-infrared optical imaging of proteases in cancer. Mol Cancer Ther 2003; 2: 489-496.
42. Lim YC, Yoo JO, Park D, et al., Antitumor effect of photodynamic therapy with chlorin-based photosensitizer DH-II-24 in colorectal carcinoma. Cancer Sci 2009; 100: 2431-2436.
43. Tomayko MM, Reynolds CP,. Determination of subcutaneous tumor size in athymic (nude) mice. Cancer Chemother Pharmacol 1989; 24: 148 - 154. (Pubitemid 19163397)
44. Euhus DM, Hudd C, LaRegina MC, Johnson FE,. Tumor measurement in the nude mouse. J Surg Oncol 1986; 31: 229 - 234. (Pubitemid 16104025)
45. Kinoshita M, Hynynen K,. Mechanism of porphyrin-induced sonodynamic effect: possible role of hyperthermia. Radiat Res 2006; 165: 299 - 306.
46. Sasaki K, Yumita N, Nishigaki R, Sakata I, Nakajima S, Umemura SI,. Pharmacokinetic study of a gallium-porphyrin photo- and sono-sensitizer, ATX-70, in tumor-bearing mice. Jpn J Cancer Res 2001; 92: 989-995. (Pubitemid 32970441)
47. Sur P, Ghosh P, Bag SP, Sur B, Chatterjee SN,. On the inhibitory activities of a new boron compound and ultrasound against the mouse ascites tumour. Chemotherapy 1999; 45: 360-369. (Pubitemid 29410815)
48. Umemura S, Kawabata K, Sugita N, Sasaki K, Yumita N,. Sonodynamic approaches to tumor treatment. Int Congr Series 2004; 1274: 164 - 168. doi: 10.1016/j.ics.2004.07.020.